Literature DB >> 18198252

New definition and natural history of patients with diffuse pulmonary arteriovenous malformations: twenty-seven-year experience.

Paola Pierucci1, Joshua Murphy, Katharine J Henderson, Deborah A Chyun, Robert I White.   

Abstract

BACKGROUND: Patients with diffuse pulmonary arteriovenous malformations (PAVM), a small but important subset of the PAVM population, have significant morbidity and mortality rates.
METHODS: Thirty-six patients (21 female and 15 male) with diffuse PAVM from a cohort of 821 consecutive patients with PAVM were evaluated. Diffuse PAVM were categorized angiographically: involvement of one or more segmental pulmonary arteries in one or both lungs. Hereditary hemorrhagic telangiectasia (HHT) status, gender, presence or absence of large (> or = 3-mm diameter artery) focal PAVM, oxygen saturations, complications including hemoptysis, years of follow-up, and survival were tabulated.
RESULTS: HHT was present in 29 of 36 patients (81%), and diffuse PAVM were more commonly bilateral (26 of 36 patients, 72%) than unilateral (10 of 36 patients, 28%) [p = 0.02]. Female gender was associated with bilateral diffuse PAVM (19 of 26 patients, 73%) [p = 0.01]. Focal PAVM were present in both groups but more commonly in patients with bilateral involvement (16 of 26 patients, 62%) [p = 0.02]. Initial oxygen saturations (pulse oximetry, standing) of patients with unilateral and bilateral diffuse PAVM were 87 +/- 7% and 79 +/- 8% (mean +/- SD), respectively (p = 0.02). The last or current values for patients with unilateral and bilateral involvement are 95 +/- 3% and 85 +/- 7%, respectively (p < 0.0001). Nine deaths occurred, and all were in patients with bilateral involvement. Deaths were due to hemoptysis of bronchial artery origin (n = 2), hemorrhage from duodenal ulcer (n = 1), spontaneous liver necrosis (n = 3), brain hemorrhage (n = 1), brain abscess (n = 1), and operative death during attempted lung transplant (n = 1).
CONCLUSIONS: Patients with diffuse PAVM are a high-risk group, and yearly follow-up is recommended.

Entities:  

Mesh:

Year:  2008        PMID: 18198252     DOI: 10.1378/chest.07-1949

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

1.  Pulmonary arteriovenous fistula within a pulmonary cyst - evaluation with CT pulmonary angiography.

Authors:  E Ghersin; D J Hildoer; J E Fishman
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

2.  Regression of pulmonary artery hypertension due to development of a pulmonary arteriovenous malformation.

Authors:  Ashfaq Hasan; B K S Sastry; M A Aleem; Gokul Reddy; Syed Mahmood
Journal:  Indian Heart J       Date:  2014-09-24

Review 3.  Embolisation for pulmonary arteriovenous malformation.

Authors:  Charlie C-T Hsu; Gigi Nc Kwan; Hannah Evans-Barns; Mieke L van Driel
Journal:  Cochrane Database Syst Rev       Date:  2018-01-04

Review 4.  Pulmonary arteriovenous malformations: endovascular therapy.

Authors:  Murthy R Chamarthy; Harold Park; Patrick Sutphin; Girish Kumar; Daniel Lamus; Sachin Saboo; Matthew Anderson; Sanjeeva P Kalva
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

Review 5.  Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations: clinical aspects.

Authors:  Nathaniel M Meier; Michael L Foster; John T Battaile
Journal:  Cardiovasc Diagn Ther       Date:  2018-06

6.  Endovascular occlusion of pulmonary arteriovenous malformations with the ArtVentive Endoluminal Occlusion System™.

Authors:  Fabio Corvino; Mattia Silvestre; Amedeo Cervo; Francesco Giurazza; Antonio Corvino; Franco Maglione
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

Review 7.  Pulmonary arteriovenous malformations.

Authors:  Claire L Shovlin
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

8.  A case of pulmonary arteriovenous malformation: role of interventional radiology in diagnosis and treatment.

Authors:  Pranav Sharma; Puneet Kochar; Salil Sharma; Nishant Gupta; Shuo Li; Kusum Hooda; Yogesh Kumar
Journal:  Ann Transl Med       Date:  2017-09

9.  Embolotherapy for pulmonary arteriovenous malformations in patients without hereditary hemorrhagic telangiectasia.

Authors:  Ji Hoon Shin; Soo Jin Park; Gi-Young Ko; Hyun-Ki Yoon; Dong-Il Gwon; Jin-Hyoung Kim; Kyu-Bo Sung
Journal:  Korean J Radiol       Date:  2010-04-29       Impact factor: 3.500

10.  Results of exercise stress testing in patients with diffuse pulmonary arteriovenous malformations.

Authors:  Joshua Murphy; Paola Pierucci; Deborah Chyun; Katharine J Henderson; Jeffrey Pollak; Robert I White; John Fahey
Journal:  Pediatr Cardiol       Date:  2009-07-28       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.